Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Targanta names two new board members
The newly appointed directors are expected to add deep operational and commercial expertise to the board as Targanta continues to build its infrastructure in support of the potential
The newly appointed directors are expected to add deep operational and commercial expertise to the board as Targanta continues to build its infrastructure in support of the potential
Ms Harris will assume responsibility for Symmetry’s consolidated financials, external reporting and standardizing global accounting. Prior to joining Symmetry, Ms Harris served as assistant controller of General Electric’s
The Phase I trial is designed as an open-label dose escalation study of CUDC-101 in patients with advanced, refractory solid tumors. CUDC-101 will be administered on days one
DiagnoCure Oncology Laboratories will promote and offer the test directly to clinicians across the US. The sales team can now actively promote the test, and the company’s US
Mr Spring joins Prometheus with 25 years of experience in finance and accounting. He comes most recently from Hyperion Therapeutics, where he served as senior vice president and
This multicenter, randomized open-label Phase II single-arm study is enrolling patients with metastatic androgen-independent prostate cancer who have developed disease progression during or within 60 days of receiving
Under the agreement, Burnham will gain access to Leap and Cyntellect will gain certain commercial rights to discoveries under the collaboration. The collaboration efforts will focus on developing
Mr Hutt has represented national trade associations for the food, prescription drug, nonprescription drug, dietary supplement, and cosmetic industries, and has been a member of the Institute of
Jack Saladow, vice president of marketing and sales at Ivera, said: “The licensing agreement between Becton, Dickinson and Company (BD) and Ivera broadens our existing patent applications and
Mr Eyal most recently served as executive vice president at NUR Macroprinters, a manufacturer of super-wide format digital printers and inks. He holds a BSc in engineering and